Search – Page 123 – Indianapolis Business Journal

Home » Search

Articles

Company news

June 1, 2015

Eli Lilly and Co. signed yet another partnership aimed at developing immune-oncology drugs. The Indianapolis-based drugmaker formed a collaboration with U.K.-based AstraZeneca plc to collaborate on a Phase 1 clinical trial for patients with advanced solid tumors. The test will study the effect of giving patients Lilly’s drug Cryamza in combination with AstraZeneca’s experimental drug […]

Rosenthal retiring as CEO, president of Conner Prairie

June 4, 2015

Conner Prairie President and CEO Ellen Rosenthal has led tremendous growth at the interactive history park in Fishers since 2003. She plans to retire at the end of the year.

After swoon, Lilly Endowment climbs back over $10B

June 4, 2015

Assets in 2014 rose from $7.7 billion to $10.1 billion, a 31-percent surge. The value of the endowment now has nearly doubled since closing 2010 at $5.3 billion.

Female libido drug nears approval with FDA panel’s backing

June 5, 2015

An experimental pill to treat low sexual desire in women moved closer to becoming the first such drug to be sold in the U.S. after regulatory advisers backed its approval.

DINING: Nourish lives up to name

June 5, 2015

The relatively spare menu offers choices constructed (when possible) from “seasonal, locally produced, family farmed and organic products.”

Lilly to launch Lantus biosimilar in Europe in third quarter

June 8, 2015

Indianapolis-based Eli Lilly and Co. plans to introduce its version of Sanofi’s Lantus insulin for diabetes in Europe in the third quarter, said Enrique Conterno, the president of Lilly Diabetes.

Fate of Eli Lilly’s potential $2B blockbuster insulin hangs on side effects

June 8, 2015

Lilly’s basal insulin peglispro proved more effective than the $7 billion blockbuster Lantus at controlling diabetics’ blood sugar, but it also had greater effect on patients’ livers and hearts. Analysts are unsure of its future.

Eli Lilly says it has ‘no intention’ to spin off animal health unit

June 10, 2015

Eli Lilly stock rose 5.4 percent per share on Tuesday, its biggest daily increase since March 2009, after Elanco President Jeffrey Simmons was asked if Lilly might one day shed the unit in an initial public offering.

Biotech with unproven Alzheimer’s drug now worth billions

June 12, 2015

Axovant Sciences Ltd., a company without a finished product or a dime of sales, has an almost $3 billion valuation after its public-market debut. The IPO shows the staggering potential for any company that can develop a successful Alzheimer’s treatment.

Startup aims to upend diabetes care with matchstick-size implant

June 15, 2015

Intarcia Therapeutics Inc. is betting its matchstick-size pump could take market share from Eli Lilly and Co., AstraZeneca Plc and Novo Nordisk A/S.

Company news

June 15, 2015

Anthem Blue Cross and Blue Shield has added St. Vincent Health to the “narrow network” of health care providers it uses for Obamacare plans. St. Vincent’s 22 hospitals and nearly 900 physicians on June 1 joined the network Anthem uses for individual health plans it sells on the online exchange created by the Affordable Care […]

Startup gives college baseball teams a competitive advantage

June 18, 2015

Noblesville-based Diamond Charts LLC has become a huge hit among college baseball teams big and small since two Rose-Hulman Institute of Technology alumni launched it in early 2013 with $200 and what seemed like a crazy idea.

Lilly buoyed by string of positive results from drug trials

June 18, 2015

After years of pipeline failures, Eli Lilly and Co. is on a bit of a hot streak. This month alone, the Indianapolis-based drugmaker has reported positive results from clinical trials of four experimental drugs.

Long-time chairman of Lilly Endowment dies at age 86

June 20, 2015

Thomas Lofton, who died Friday, provided legal counsel to the Indianapolis foundation for decades before becoming its chairman in 1993.

Company news

June 22, 2015

Eli Lilly and Co.’s shares have risen more than 5 percent this month—and more than 20 percent so far this year—as its pipeline has delivered a string of positive results. This month alone, the Indianapolis-based drugmaker has reported positive results from clinical trials of four experimental drugs. And next month, Lilly will release more data […]

« Previous 1 … 121 122 123 124 125 … 221 Next »

Search Results

4,414 results for '\"eli lilly\"'

Articles

Company news

Rosenthal retiring as CEO, president of Conner Prairie

After swoon, Lilly Endowment climbs back over $10B

Female libido drug nears approval with FDA panel’s backing

DINING: Nourish lives up to name

Lilly to launch Lantus biosimilar in Europe in third quarter

Fate of Eli Lilly’s potential $2B blockbuster insulin hangs on side effects

Eli Lilly says it has ‘no intention’ to spin off animal health unit

Biotech with unproven Alzheimer’s drug now worth billions

Startup aims to upend diabetes care with matchstick-size implant

Company news

Startup gives college baseball teams a competitive advantage

Lilly buoyed by string of positive results from drug trials

Long-time chairman of Lilly Endowment dies at age 86

Company news

Lilly drug regimen costing $9,200 a month scores zero in study

Lilly facing first trials over Cymbalta withdrawal symptoms

British court ruling backs patent protecting Lilly’s Alimta

London mayor discussing $16B biotech fund with Lilly, others

LOPRESTI: Whom to draft/hire? Here are five picks that panned out